EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Psilocybin Synthesis by Co‐Immobilized Enzymes

Tim Schäfer, Alexander Sherwood, Thomas Kirkland, Thomas Krüger, Jakob Worbs, Olaf Kniemeyer, Markus Gressler, Dirk Hoffmeister

Chemistry – A European Journal · 2025

DOI: 10.1002/chem.202501037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Tim Schäfer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Microbiology, Friedrich Schiller University, Beutenbergstrasse 11a, Jena, Germany. Hauptthemen laut MEDLINE: Psilocybin, Enzymes, Immobilized, Psilocybe. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Usona Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced clinical trials investigate the Psilocybe magic mushroom natural product psilocybin as a treatment against major depressive disorder. Currently, synthetic material is used to meet the demand for legitimate pharmaceutical purposes. Here, we report an in vitro approach to biocatalytically produce psilocybin on a solid‐phase matrix charged with five covalently bound biosynthetic enzymes. These enzymes include three Psilocybe enzymes: IasA*, an engineered l ‐tryptophan decarboxylase/aromatic aldehyde synthase, the 4‐hydroxytryptamine kinase PsiK and the norbaeocystin methyltransferase PsiM, along with Escherichia coli nucleosidase MtnN and adenine deaminase Ade. In a proof‐of‐principle experiment, this enzyme‐charged resin allowed for quantitative turnover of 4‐hydroxy‐ l ‐tryptophan into psilocybin. This facile process i) represents a sustainable approach with reusable enzymes, ii) circumvents the drawbacks of in vivo processes while harnessing the selectivity of enzymatic catalysis and iii) helps access an urgently needed drug candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsilocybinEnzymes, ImmobilizedPsilocybeBiocatalysisEscherichia coliMethyltransferases

Stichwörter der Autor:innen

biotechnologyenzymeimmobilizationnatural productspsilocybin

Substanzen

PsilocybinEnzymes, ImmobilizedMethyltransferases

Autor:innen und Institutionen

  • Pharmaceutical Microbiology, Friedrich Schiller University, Beutenbergstrasse 11a, Jena, Germany.
  • Pharmaceutical Microbiology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Beutenbergstrasse 11a, Jena, Germany.
  • The Usona Institute, 2780 Woods Hollow Road, Madison, WI, USA.
  • Research & Development, Promega Corporation, 2800 Woods Hollow Road, Madison, WI, USA.
  • Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Beutenbergstrasse 11a, Jena, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft
  • Usona Institute

Zitieren

APA

Schäfer, T., Sherwood, A., Kirkland, T., Krüger, T., Worbs, J., Kniemeyer, O., Gressler, M., & Hoffmeister, D. (2025). In Vitro Psilocybin Synthesis by Co‐Immobilized Enzymes. Chemistry – A European Journal. https://doi.org/10.1002/chem.202501037

Vancouver

Schäfer T, Sherwood A, Kirkland T, Krüger T, Worbs J, Kniemeyer O, et al. In Vitro Psilocybin Synthesis by Co‐Immobilized Enzymes. Chemistry – A European Journal. 2025. doi:10.1002/chem.202501037

BibTeX
@article{Schfer2025,
  author = {Schäfer, Tim and Sherwood, Alexander and Kirkland, Thomas and Krüger, Thomas and Worbs, Jakob and Kniemeyer, Olaf and Gressler, Markus and Hoffmeister, Dirk},
  title = {In Vitro Psilocybin Synthesis by Co‐Immobilized Enzymes},
  journal = {Chemistry – A European Journal},
  year = {2025},
  doi = {10.1002/chem.202501037}
}
Kostenlos starten →